SCHEMBL14715519

SCHEMBL14715519

COc1cccc(NC(=O)c2ccc(C)c(-c3nc(N)nc4ccccc34)c2)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.50
NPSR1 Q6W5P4 2/20 0.47
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
HSD17B10 Q99714 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NAMPT P43490 1/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MAPT P10636 3/20 0.43
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPK14 Q16539 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
LCK P06239 1/20 0.42
KDR P35968 1/20 0.42
JAK3 P52333 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14715462 0.85 ALDH1A1 (0.58) ADORA2AGAASMN1; SMN2NPC1MAPT
SCHEMBL14715533 0.85 ALDH1A1 (0.58) ADORA2ASMN1; SMN2HSD17B10NPC1RAB9A
SCHEMBL14715543 0.82 LCK (0.49) ADORA2ANPSR1GAAHTTMAPT
SCHEMBL14715517 0.82 POLB (0.58) ADORA2ASMN1; SMN2HSD17B10L3MBTL1NPC1
SCHEMBL14715491 0.82 MAPT (0.47) ADORA2ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL14715473 0.82 ADORA2A (0.45) ADORA2ANPSR1GAAHTTSMN1; SMN2
SCHEMBL5500716 0.79 LCK (0.68) MAPK14LCKKDRJAK3
SCHEMBL14715496 0.78 PLAU (0.53) NPSR1HTTSMN1; SMN2NPC1RAB9A
SCHEMBL14715638 0.73 ADORA2A (0.46) ADORA2ANPSR1SMN1; SMN2NPC1RAB9A
SCHEMBL14715526 0.72 TAS1R3 (0.48) ADORA2ANPSR1HTTSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-B2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2019-10-02 EP disclosed
EP-1836174-B1 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2013-02-27 EP disclosed